These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictors for starting depot administration of risperidone in chronic users of antipsychotics. Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H. J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430 [Abstract] [Full Text] [Related]
8. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study. Gründer G, Heinze M, Cordes J, Mühlbauer B, Juckel G, Schulz C, Rüther E, Timm J, NeSSy Study Group. Lancet Psychiatry; 2016 Aug; 3(8):717-729. PubMed ID: 27265548 [Abstract] [Full Text] [Related]
9. A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic. Malla AK, Norman RM, Scholten DJ, Zirul S, Kotteda V. J Clin Psychiatry; 2001 Mar; 62(3):179-84. PubMed ID: 11305704 [Abstract] [Full Text] [Related]
14. Anticholinergic use in children and adolescents after initiation of antipsychotic therapy. Hong IS, Bishop JR. Ann Pharmacother; 2010 Dec; 44(7-8):1171-80. PubMed ID: 20587746 [Abstract] [Full Text] [Related]
15. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients. Taylor DM, Young CL, Mace S, Patel MX. J Clin Psychiatry; 2004 Aug; 65(8):1076-83. PubMed ID: 15323592 [Abstract] [Full Text] [Related]
18. Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes. Weinmann S, Janssen B, Gaebel W. J Clin Psychiatry; 2004 Aug 29; 65(8):1099-105. PubMed ID: 15323596 [Abstract] [Full Text] [Related]
19. Anticholinergic use in hospitalised schizophrenic patients in Belgium. De Hert M, Wampers M, van Winkel R, Peuskens J. Psychiatry Res; 2007 Aug 30; 152(2-3):165-72. PubMed ID: 17445906 [Abstract] [Full Text] [Related]
20. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective. Dencker SJ. J Clin Psychiatry; 1984 May 30; 45(5 Pt 2):22-7. PubMed ID: 6143744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]